SEC Form 4 · accession 0001615774-16-005992
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Daugherty
Officer — See remarks
Period of report
Jun 21, 2016
Accepted (ET)
Jun 21, 2016 · 12:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Jun 21, 2016 | P | 100,000 | $2.00 | A | 100,000 | I | By IRA |
| Common Stock, $0.001 par value | holding | — | — | — | 65,777 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Chief Scientific Officer and Secretary